Abstract:Ovarian cancer (OC) remains the deadliest gynecological malignancy, with alarming projections indicating a 42% increase in new cases and a 51% rise in mortality by 2040. This review explores the challenges in OC treatment, focusing on chemoresistance mechanisms and the potential of extracellular vesicles (EVs) as drug delivery agents. Despite advancements in treatment strategies, including cytoreductive surgery, platinum-based chemotherapy, and targeted therapies, the high recurrence rate underscores the need for innovative approaches. Key resistance mechanisms include drug efflux, apoptosis disruption, enhanced DNA repair, cancer stem cells, immune evasion, and the complex tumor microenvironment. Cancer-associated fibroblasts and extracellular vesicles play crucial roles in modulating the tumor microenvironment and facilitating chemoresistance. EVs, naturally occurring nanovesicles, emerge as promising drug carriers due to their low toxicity, high biocompatibility, and inherent targeting capabilities. They have shown potential in delivering chemotherapeutics like doxorubicin, cisplatin, and paclitaxel, as well as natural compounds such as curcumin and berry anthocyanidins, enhancing therapeutic efficacy while reducing systemic toxicity in OC models. However, challenges such as low production yields, heterogeneity, rapid clearance, and inefficient drug loading methods need to be addressed for clinical application. Ongoing research aims to optimize EV production, loading efficiency, and targeting, paving the way for novel and more effective therapeutic strategies in OC treatment. Overcoming these obstacles is crucial to unlocking the full potential of EV-based therapies and improving outcomes for OC patients.

Unraveling the extracellular vesicle network: insights into ovarian cancer metastasis and chemoresistance

Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion

Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications

Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors

Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials

Non-Coding RNAs Delivery by Small Extracellular Vesicles and Their Applications in Ovarian Cancer

Exosome Mediated Multidrug Resistance in Cancer.

Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance

Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis

The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends

Exosomal Cargo in Ovarian Cancer Dissemination

Ovarian cancer extracellular vesicle biomarkers

The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Extracellular Vesicles in Inter-Kingdom Communication in Gastrointestinal Cancer.

Role of Exosomes in the Invasion and Metastasis of Ovarian Cancer and Application Potential of Clinical Diagnosis and Treatment

The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance

The role of extracellular vesicles in cancer

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Extracellular vesicles in anti-tumor drug resistance: Mechanisms and therapeutic prospects

Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression